Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease

Journal Title: Advances in Hygiene and Experimental Medicine - Year 2016, Vol 70, Issue

Abstract

Huntington’s disease (HD) is an incurable, devastating neurodegenerative disease with a known genetic background and autosomally dominant inheritance pattern. HTT gene mutation (mHTT) is associated with polymorphic fragment elongation above 35 repeats of the CAG triplet. The mHTT product is an altered protein with a poly-Q elongated fragment, with the highest expression determined in the central nervous system (CNS) and with differentiated expression outside the CNS. A drastic loss of striatal and deeper layers of the cerebral cortex neurons was determined in the CNS, but muscle and body weight mass loss with dysfunction of many organs was also observed. HD symptoms include neurological disturbances, such as choreal movements with dystonia, speech and swallowing impairments, and additionally a variety of psychiatric and behavioral symptoms with cognitive decline have been described.They are the result of disturbances of several cellular pathways related to signal transmission, mitochondrial dysfunction and energy metabolism impairment shown by gene and protein expression and alteration of their functions. Impairment of energy processes demonstrated by a decrease of ATP production and increase of oxidative stress markers was determined in- and outside of the CNS in glycolysis, the Krebs cycle and the electron transport chain. A correlation between the increase of energy metabolism impairment level and the increase in number of CAG repeats in HTT has often been described. The energy metabolism study is an initial stage of sensitive biomarkers and a new therapeutic investigative option for early application in order to inhibit pathological processes in HD.Identification of pathological changes outside the CNS requires a reevaluation of diagnostic and therapeutic rules in HD.

Authors and Affiliations

Jolanta Krzysztoń-Russjan

Keywords

Related Articles

Fentanyl and its derivatives as a group of new psychoactive substances (designer drugs)

Fentanyl has been known for many years. It has been widely used in emergency medicine and anaesthesiology. Due to its strong action, it gained a reputation of a popular addictive drug. Over the past years, fentanyl deriv...

Comparison of microbiological and physicochemical methods for enumeration of microorganisms

Determination of the number of cultured bacteria is essential for scientific and industrial practice. A spread plate technique is the most common and accurate method for counting of microorganisms. However, time consumin...

Selenium in Graves' disease

The aim of this study was to present the current state of knowledge of the role of selenium in Graves’ disease. Recently, in the pathogenesis and course of this autoimmune disease, more attention has been paid to the rel...

Investigations of seborrheic dermatitis. Part I. The role of selected cytokines in the pathogenesis of seborrheic dermatitis

Introduction: The etiology of seborrheic dermatitis is not fully understood. It has been observed that a number of anascogenic yeasts of Malassezia spp. is related to the intensity of the symptoms. The aim of the study i...

Mast cells in viral infections

There are some premises suggesting that mast cells are involved in the mechanisms of anti-virus defense and in viral disease pathomechanisms. Mast cells are particularly numerous at the portals of infections and thus...

Download PDF file
  • EP ID EP206142
  • DOI -
  • Views 159
  • Downloads 0

How To Cite

Jolanta Krzysztoń-Russjan (2016). Pathophysiology and molecular basis of selected metabolic abnormalities in Huntington’s disease. Advances in Hygiene and Experimental Medicine, 70(), 1331-1342. https://europub.co.uk/articles/-A-206142